Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10335391
Stabilized oxymetazoline formulations and their uses
granted -
US 10336769
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
granted -
US 10335478
Avirulent, immunogenic flavivirus chimeras
granted -
US 10336824
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of thereof
granted -
US 10335476
Vaccine to protect against Ehrlichia infection
granted -
US 10335466
AADC polynucleotides for the treatment of parkinson's disease
granted -
US 10335465
Mutant OPAA enzyme with increased catalytic efficiency on organophosphorus compound GP
granted -
US 10335470
Immunogenic compositions comprising progastrin and uses thereof
granted -
US 10335463
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 10337029
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10329338
Nucleic acid construct encoding an agonistic anti-CD40 antibody and a type I interferon
granted -
US 10329306
Crystalline form of 1-(1-methyl-1H-pyrazol-4-yl)-N-((IR,5S,7S)-9-methyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-yl)-1H-indole-3-carboxamide
granted -
US 10329326
Melanocortin 1 receptor ligands and methods of use
granted -
US 10329260
Human plasma kallikrein inhibitors
granted -
US 10329259
Pyrazole derivatives and their use as cannabinoid receptor mediators
granted -
US 10328159
Enhanced loading of intact, bacterially derived vesicles with small molecule compounds
granted -
US 10328109
Targeted adenoviruses and methods of making, isolating, and using
granted -
US 10328095
Resorbable oxidized cellulose embolization microspheres
granted -
US 10328115
Modulators of complement activity
granted -
US 10328040
Therapeutic methods
granted -
US 10330685
Markers for sepsis treatment
granted -
US 10328026
Synthetic nanostructures including nucleic acids and/or other entities
granted -
US 10327461
Food thickening agent, method for producing food thickening agent
granted -
US 10328139
Live-attenuated vaccine against plague
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.